BR1100358A - Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação - Google Patents

Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação

Info

Publication number: BR1100358A
Authority: BR; Brazil
Prior art keywords: antibody; purified; column; prepn; igg antibody
Prior art date: 1990-10-17

Application number

BR1100358-8A

Other languages

English (en)

Inventor

Paul Ian Nicholas Ramage

Geoffrey Allen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-17

Filing date

1997-04-28

Publication date

2000-03-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10683866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100358(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-04-28 Application filed filed Critical

1997-04-28 Priority to BR1100358-8A priority Critical patent/BR1100358A/pt

2000-03-28 Publication of BR1100358A publication Critical patent/BR1100358A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR1100358-8A 1990-10-17 1997-04-28 Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação BR1100358A (pt)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
BR1100358-8A BR1100358A (pt)	1990-10-17	1997-04-28	Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909022547A GB9022547D0 (en)	1990-10-17	1990-10-17	Purified immunoglobulin
BR1100358-8A BR1100358A (pt)	1990-10-17	1997-04-28	Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação

Publications (1)

Publication Number	Publication Date
BR1100358A true BR1100358A (pt)	2000-03-28

Family

ID=10683866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR1100358-8A BR1100358A (pt)	1990-10-17	1997-04-28	Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação

Country Status (29)

Country	Link
US (1)	US5644036A (pt)
EP (1)	EP0504363B2 (pt)
JP (1)	JP2638680B2 (pt)
KR (2)	KR960015399B1 (pt)
AT (2)	ATE162552T1 (pt)
AU (3)	AU658926B2 (pt)
BE (1)	BE1004226A5 (pt)
BR (1)	BR1100358A (pt)
CA (1)	CA2069481C (pt)
CH (2)	CH681305A5 (pt)
DE (1)	DE69128774T3 (pt)
DK (1)	DK0504363T4 (pt)
ES (2)	ES2081742B1 (pt)
FI (2)	FI110003B (pt)
FR (2)	FR2668164A1 (pt)
GB (2)	GB9022547D0 (pt)
GR (3)	GR910100425A (pt)
HU (1)	HUT64601A (pt)
IE (1)	IE913560A1 (pt)
IL (3)	IL99761A0 (pt)
IT (1)	IT1250064B (pt)
LU (1)	LU88122A1 (pt)
MX (1)	MX9203794A (pt)
MY (2)	MY119030A (pt)
NZ (2)	NZ240247A (pt)
PT (2)	PT99248B (pt)
TW (1)	TW283710B (pt)
WO (1)	WO1992007084A1 (pt)
ZA (2)	ZA926191B (pt)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
AU671807B2 (en) *	1991-10-15	1996-09-12	Btg International Limited	CDw52 - specific antibody for treatment of T-cell mediated inflammation of the joints
GB9125768D0 (en) *	1991-12-04	1992-02-05	Hale Geoffrey	Therapeutic method
GB9300501D0 (en) *	1993-01-09	1993-03-03	Wellcome Found	Purification of immunoglobulin
CA2228128C (fr) †	1995-08-01	2011-03-29	Pasteur Merieux Serums & Vaccins	Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
US6090382A (en) *	1996-02-09	2000-07-18	Basf Aktiengesellschaft	Human antibodies that bind human TNFα
CZ292465B6 (cs)	1996-02-09	2003-09-17	Abbott Laboratories (Bermuda) Ltd.	Lidské protilátky k lidskému TNFalfa
GB9603256D0 (en) *	1996-02-16	1996-04-17	Wellcome Found	Antibodies
US20030023043A1 (en) *	2000-03-02	2003-01-30	Kazuhisa Uchida	Method of separating and purifying protein
EP2336149A1 (en)	2001-03-09	2011-06-22	Chugai Seiyaku Kabushiki Kaisha	Protein purification method
DE60213248T2 (de) *	2001-06-05	2006-11-30	Genetics Institute, LLC, Cambridge	Verfahren zur reinigung hochanionischer proteine
GB0220894D0 (en) *	2002-09-09	2002-10-16	Millipore Uk Ltd	Method of separation
EP2261230B1 (en)	2002-09-11	2017-05-10	Chugai Seiyaku Kabushiki Kaisha	Protein purification method
CN1705679B (zh)	2002-10-15	2011-04-06	英特塞尔股份公司	编码b族链球菌粘着因子的核酸、b族链球菌的粘着因子和它们的用途
GB0304576D0 (en) *	2003-02-28	2003-04-02	Lonza Biologics Plc	Protein a chromatography
CA2548947A1 (en) *	2003-12-22	2005-07-14	Genzyme Corporation	Anti-cd52 antibody treatment for diabetes
PT1869065T (pt)	2005-03-11	2020-06-18	Wyeth Llc	Método de cromatografia de partição fraca
US9096651B2 (en)	2007-09-26	2015-08-04	Chugai Seiyaku Kabushiki Kaisha	Method of modifying isoelectric point of antibody via amino acid substitution in CDR
PL3514180T3 (pl)	2008-04-11	2024-08-12	Chugai Seiyaku Kabushiki Kaisha	Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
MY160126A (en)	2009-05-13	2017-02-28	Genzyme Corp	Anti-human cd52 immunoglobulins
WO2010132683A1 (en)	2009-05-13	2010-11-18	Genzyme Corporation	Methods and compositions for treating lupus
WO2011090719A2 (en) *	2009-12-29	2011-07-28	Dr. Reddy's Laboratories Ltd.	Protein purification by ion exchange
EP2583973B1 (en)	2010-06-21	2018-03-21	Kyowa Hakko Kirin Co., Ltd.	Method for purifying protein using amino acid
RU2467783C2 (ru) *	2010-07-30	2012-11-27	Закрытое акционерное общество "БиоХимМак СТ"	Способ хроматографического выделения иммуноглобулина
TWI812066B (zh)	2010-11-30	2023-08-11	日商中外製藥股份有限公司	具有鈣依存性的抗原結合能力之抗體
EP2702077A2 (en)	2011-04-27	2014-03-05	AbbVie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
GB201109238D0 (en) *	2011-06-01	2011-07-13	Antitope Ltd	Antibodies
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Protein purification methods to reduce acidic species
US9249182B2 (en)	2012-05-24	2016-02-02	Abbvie, Inc.	Purification of antibodies using hydrophobic interaction chromatography
US9650411B2 (en)	2012-08-07	2017-05-16	Kyowa Hakko Kirin Co., Ltd.	Method of purifying protein
SG11201504249XA (en)	2012-09-02	2015-07-30	Abbvie Inc	Methods to control protein heterogeneity
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
EP2830651A4 (en)	2013-03-12	2015-09-02	Abbvie Inc	HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
WO2014159579A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2014151878A2 (en)	2013-03-14	2014-09-25	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
AU2013203043B2 (en) *	2013-03-15	2016-10-06	Takeda Pharmaceutical Company Limited	Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
AR095199A1 (es)	2013-03-15	2015-09-30	Genzyme Corp	Anticuerpos anti-cd52
WO2015051293A2 (en)	2013-10-04	2015-04-09	Abbvie, Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
CA2935143C (en)	2013-12-27	2024-05-07	Chugai Seiyaku Kabushiki Kaisha	Method for purifying antibody having low isoelectric point
AR103161A1 (es)	2014-12-19	2017-04-19	Chugai Pharmaceutical Co Ltd	Anticuerpos antimiostatina y regiones fc variantes así como métodos de uso
WO2017022651A1 (ja)	2015-07-31	2017-02-09	中外製薬株式会社	アニオン性ポリマーによる抗体を含有する組成物の精製方法
CA3031028C (en)	2016-07-25	2024-02-13	Lu Wang	Affinity chromatography wash buffer
TW202300168A (zh)	2016-08-05	2023-01-01	日商中外製藥股份有限公司	Il-8相關疾病之治療用或預防用組成物
US20220177518A1 (en)	2019-03-29	2022-06-09	Asahi Kasei Medical Co., Ltd.	Method for purifying protein
US20220212167A1 (en)	2019-04-08	2022-07-07	Asahi Kasei Medical Co., Ltd.	Polyamide medium for purifying protein-containing solution and method for producing polyamide medium
KR20210149779A (ko)	2019-04-10	2021-12-09	추가이 세이야쿠 가부시키가이샤	Fc 영역 개변 항체의 정제 방법
KR20240021151A (ko)	2021-06-10	2024-02-16	미쯔비시 케미컬 주식회사	합성 흡착제, 항체의 정제 방법 및 항체의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5118796A (en) *	1987-12-09	1992-06-02	Centocor, Incorporated	Efficient large-scale purification of immunoglobulins and derivatives
CA1339198C (en) *	1988-02-12	1997-08-05	Gregory Paul Winter	Antibodies to the antigen campath-1

1990
- 1990-10-17 GB GB909022547A patent/GB9022547D0/en active Pending
1991
- 1991-10-16 IL IL99761A patent/IL99761A0/xx unknown
- 1991-10-16 BE BE9100946A patent/BE1004226A5/fr not_active IP Right Cessation
- 1991-10-16 MY MYPI91001909A patent/MY119030A/en unknown
- 1991-10-16 IE IE356091A patent/IE913560A1/en not_active IP Right Cessation
- 1991-10-16 IT ITRM910788A patent/IT1250064B/it active IP Right Grant
- 1991-10-16 IL IL10272691A patent/IL102726A/en not_active IP Right Cessation
- 1991-10-16 GR GR910100425A patent/GR910100425A/el unknown
- 1991-10-16 FR FR9112738A patent/FR2668164A1/fr active Granted
- 1991-10-16 MY MYPI92001385A patent/MY136210A/en unknown
- 1991-10-16 NZ NZ240247A patent/NZ240247A/en not_active IP Right Cessation
- 1991-10-16 ZA ZA926191A patent/ZA926191B/xx unknown
- 1991-10-16 ZA ZA918259A patent/ZA918259B/xx unknown
- 1991-10-16 NZ NZ244114A patent/NZ244114A/en not_active IP Right Cessation
- 1991-10-16 TW TW080108178A patent/TW283710B/zh not_active IP Right Cessation
- 1991-10-16 PT PT99248A patent/PT99248B/pt not_active IP Right Cessation
- 1991-10-17 ES ES09250029A patent/ES2081742B1/es not_active Expired - Lifetime
- 1991-10-17 AT AT91917891T patent/ATE162552T1/de not_active IP Right Cessation
- 1991-10-17 AT AT0900791A patent/ATA900791A/de not_active Application Discontinuation
- 1991-10-17 ES ES91917891T patent/ES2112865T5/es not_active Expired - Lifetime
- 1991-10-17 CA CA002069481A patent/CA2069481C/en not_active Expired - Lifetime
- 1991-10-17 DK DK91917891T patent/DK0504363T4/da active
- 1991-10-17 WO PCT/GB1991/001816 patent/WO1992007084A1/en active IP Right Grant
- 1991-10-17 CH CH1901/92A patent/CH681305A5/fr not_active IP Right Cessation
- 1991-10-17 DE DE69128774T patent/DE69128774T3/de not_active Expired - Lifetime
- 1991-10-17 KR KR1019920701427A patent/KR960015399B1/ko not_active IP Right Cessation
- 1991-10-17 EP EP91917891A patent/EP0504363B2/en not_active Expired - Lifetime
- 1991-10-17 CH CH2655/92A patent/CH681455A5/fr not_active IP Right Cessation
- 1991-10-17 JP JP3516509A patent/JP2638680B2/ja not_active Expired - Lifetime
- 1991-10-17 HU HU9202000A patent/HUT64601A/hu unknown
1992
- 1992-02-28 GB GB9209529A patent/GB2253397A/en not_active Withdrawn
- 1992-05-25 FI FI922380A patent/FI110003B/fi not_active IP Right Cessation
- 1992-05-27 LU LU88122A patent/LU88122A1/xx unknown
- 1992-06-17 FI FI922824A patent/FI110002B/fi not_active IP Right Cessation
- 1992-06-29 MX MX9203794A patent/MX9203794A/es unknown
- 1992-08-04 IL IL102726A patent/IL102726A0/xx unknown
- 1992-08-13 FR FR9209998A patent/FR2677997A1/fr not_active Withdrawn
- 1992-09-23 AU AU25321/92A patent/AU658926B2/en not_active Expired
- 1992-10-20 GR GR920100471A patent/GR920100471A/el unknown
- 1992-10-20 PT PT100988A patent/PT100988B/pt not_active IP Right Cessation
- 1992-10-30 KR KR1019920702699A patent/KR100193314B1/ko not_active IP Right Cessation
1994
- 1994-08-11 AU AU70242/94A patent/AU7024294A/en not_active Abandoned
- 1994-10-07 US US08/319,598 patent/US5644036A/en not_active Expired - Lifetime
1997
- 1997-04-28 BR BR1100358-8A patent/BR1100358A/pt active IP Right Grant
- 1997-11-13 AU AU45218/97A patent/AU716402B2/en not_active Expired
1998
- 1998-04-10 GR GR980400777T patent/GR3026588T3/el unknown

Also Published As

Publication number	Publication date
FI922380A0 (fi)	1992-05-25
AU658926B2 (en)	1995-05-04
CH681305A5 (pt)	1993-02-26
TW283710B (pt)	1996-08-21
IL102726A (en)	2002-08-14
ES2112865T5 (es)	2007-09-16
CA2069481A1 (en)	1992-04-18
ZA926191B (en)	1993-04-16
GB2253397A (en)	1992-09-09
KR100193314B1 (ko)	1999-06-15
KR960015399B1 (ko)	1996-11-13
CA2069481C (en)	2003-07-29
MX9203794A (es)	1992-07-01
DE69128774T2 (de)	1998-06-04
GR920100471A (el)	1994-06-30
ES2081742A1 (es)	1996-03-01
PT100988B (pt)	1999-08-31
NZ244114A (en)	1995-06-27
GB9209529D0 (en)	1992-07-01
HU9202000D0 (en)	1992-10-28
ATA900791A (de)	1996-06-15
JP2638680B2 (ja)	1997-08-06
FI922824A (fi)	1992-06-17
JPH05504579A (ja)	1993-07-15
IL102726A0 (en)	1993-01-31
AU2532192A (en)	1993-02-11
AU649078B2 (en)	1994-05-12
PT100988A (pt)	1994-02-28
DE69128774T3 (de)	2007-08-16
FR2668164A1 (fr)	1992-04-24
CH681455A5 (pt)	1993-03-31
IT1250064B (it)	1995-03-30
FR2668164B1 (pt)	1995-04-14
MY119030A (en)	2005-03-31
EP0504363A1 (en)	1992-09-23
WO1992007084A1 (en)	1992-04-30
BE1004226A5 (fr)	1992-10-13
HUT64601A (en)	1994-01-28
US5644036A (en)	1997-07-01
EP0504363B2 (en)	2007-02-07
AU7024294A (en)	1995-01-05
ITRM910788A0 (it)	1991-10-16
ES2081742B1 (es)	1996-10-01
FI110002B (fi)	2002-11-15
MY136210A (en)	2008-08-29
PT99248A (pt)	1993-06-30
ATE162552T1 (de)	1998-02-15
IE913560A1 (en)	1992-04-22
FR2677997A1 (fr)	1992-12-24
DE69128774D1 (de)	1998-02-26
EP0504363B1 (en)	1998-01-21
FI922380A (fi)	1992-05-25
FI922824A0 (fi)	1992-06-17
DK0504363T4 (da)	2007-05-29
ES2112865T3 (es)	1998-04-16
ZA918259B (en)	1993-04-16
FI110003B (fi)	2002-11-15
ITRM910788A1 (it)	1993-04-16
GR910100425A (el)	1992-09-25
KR920703108A (ko)	1992-12-17
GB9022547D0 (en)	1990-11-28
IL99761A0 (en)	1992-08-18
DK0504363T3 (da)	1998-09-21
NZ240247A (en)	1994-03-25
PT99248B (pt)	1999-04-30
LU88122A1 (fr)	1993-03-15
GR3026588T3 (en)	1998-07-31
AU8729491A (en)	1992-05-20
AU716402B2 (en)	2000-02-24
AU4521897A (en)	1998-02-12

Publication	Publication Date	Title
BR1100358A (pt)	2000-03-28	Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação
Grandics et al.	1984	Phosphorylation invivo of rat hepatic glucocorticoid receptor
EP0185034A4 (pt)	1988-01-28
AU7067287A (en)	1987-10-01	Method and apparatus for separating proteins
EP0087686A3 (en)	1985-09-18	Homogeneous human immune interferon and process therefor
US5338834A (en)	1994-08-16	Ultrapure human interleukin-6
RU95112503A (ru)	1996-12-20	Способ выделения предварительно отобранного гемоглобина и очищенный препарат гемоглобина
Dimitrijevic et al.	1979	Purification and characterization of an estrogen-binding peroxidase from human fetuses
Van Kamp et al.	1971	One-step preparation of the polypeptide chains of α-crystallin
Kurochkina et al.	1989	Isolation of modified histone H3 from ultraviolet-irradiated deoxyribonucleoprotein by reversed-phase high-performance liquid chromatography
ES2068392T3 (es)	1995-04-16	Procedimiento de purificacion de interferon.
LUSTENBERGER et al.	1985	Purification of Glucocorticoid Receptor from Rabbit Liver by Steroid Affinity Chromatography
Deng	1982	PURIFICATION OF HUMAN INTERFERON-? BY ANTIBODY AFFINITY CHROMATOGRAPY
FR2411202A1 (fr)	1979-07-06	Procede d'extraction et de purification de la globuline transporteur d'hormones thyroidiennes tbg

Legal Events

Date	Code	Title
1997-09-02	AN	Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
1999-11-09	FGAN	Processing applications according to articles 230 and 231 of law 9.279/96: granting
2000-03-28	NB	Patent issued - articles 230 and 231 of law 9279/96